Skip to content
Screener

TG Therapeutics TGTX Book value per share

Book value per share at other companies

Biogen logo
BiogenBIIB
$126.75+5.4%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$1.81+502%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$0.16-103%
Vor Biopharma logo
Vor BiopharmaVOR
-$3.50-133%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$11.70-34.9%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$2.86-286%

Other financials

Income statement

See full
Revenue$240.3M+70.3%
Gross profit$199.1M+62.9%
Operating income$21.7M-37.8%
Net income$7.8M-72.4%
EPS (diluted)$0.05-70.6%

Balance sheet

See full
Cash & equivalents$482.6M+274%
Total debt$754.4M+197%
Total equity$604.1M+119%
Total assets$1.6B+133%

Cash flow

See full
Operating cash flow$39.3M
CapEx$293.0K+598%
Free cash flow$39.0M

Valuation

See full
Market cap$7.64B+73.6%
Enterprise value$7.91B+74.9%
P/E17.3×-55.5×
P/S9.6×-0.1×

Profitability

See full
Gross margin82.4%-4.6pp
Operating margin17.1%-1.9pp
Net margin55.2%+41.9pp
FCF margin-6,328.4%+4,773pp

Returns & leverage

See full
Return on equity100.3%+73.6pp
Debt / equity1.2×+0.3×
Current ratio4.3×+0.4×

Where this comes from

Calculated from TG Therapeutics’s reported figures.

Based on the most recent quarter.

The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:01 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437749-26-025955

FAQ

What is TG Therapeutics's book value per share?
TG Therapeutics (TGTX) reported book value per share of $3.84 in Q2 2026.
How has TG Therapeutics's book value per share changed year-over-year?
TG Therapeutics's book value per share increased by 125.9% year-over-year, from $1.70 to $3.84.
What is the long-term trend for TG Therapeutics's book value per share?
Over 5 years (2020 to 2025), TG Therapeutics's book value per share has grown at a -2.3% compound annual growth rate (CAGR), from $4.50 to $4.01.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about TG Therapeutics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude